Natera Total Long Term Liabilities 2014-2025 | NTRA

Natera total long term liabilities from 2014 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Natera total long term liabilities for the quarter ending March 31, 2025 were $0.127B, a 65.5% decline year-over-year.
  • Natera total long term liabilities for 2024 were $0.121B, a 67.14% decline from 2023.
  • Natera total long term liabilities for 2023 were $0.369B, a 2.41% decline from 2022.
  • Natera total long term liabilities for 2022 were $0.378B, a 3.84% increase from 2021.
Natera Annual Total Long Term Liabilities
(Millions of US $)
2024 $121
2023 $369
2022 $378
2021 $364
2020 $247
2019 $124
2018 $122
2017 $84
2016 $8
2015 $0
2014 $24
2013 $22
Natera Quarterly Total Long Term Liabilities
(Millions of US $)
2025-03-31 $127
2024-12-31 $121
2024-09-30 $411
2024-06-30 $366
2024-03-31 $368
2023-12-31 $369
2023-09-30 $372
2023-06-30 $375
2023-03-31 $377
2022-12-31 $378
2022-09-30 $380
2022-06-30 $371
2022-03-31 $371
2021-12-31 $364
2021-09-30 $353
2021-06-30 $353
2021-03-31 $354
2020-12-31 $247
2020-09-30 $245
2020-06-30 $243
2020-03-31 $123
2019-12-31 $124
2019-09-30 $158
2019-06-30 $163
2019-03-31 $144
2018-12-31 $122
2018-09-30 $119
2018-06-30 $118
2018-03-31 $118
2017-12-31 $84
2017-09-30 $82
2017-06-30 $9
2017-03-31 $9
2016-12-31 $8
2016-09-30 $6
2016-06-30 $2
2016-03-31
2015-12-31
2015-09-30 $21
2015-06-30 $25
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2013-12-31 $22
Sector Industry Market Cap Revenue
Medical Medical Services $22.963B $1.697B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $144.179B 27.04
CVS Health (CVS) United States $86.198B 10.71
Elevance Health (ELV) United States $84.314B 10.88
Cencora (COR) United States $57.484B 20.00
DiDi Global (DIDIY) China $23.485B 24.95
Labcorp Holdings (LH) United States $21.509B 17.45
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.205B 0.00
Solventum (SOLV) United States $12.912B 13.67
CochLear (CHEOY) Australia $12.870B 0.00
ICON (ICLR) Ireland $11.851B 11.02
Revvity (RVTY) United States $11.644B 20.04
Viatris (VTRS) United States $10.704B 3.68
Avantor (AVTR) United States $9.363B 13.60
HealthEquity (HQY) United States $9.068B 39.72
Medpace Holdings (MEDP) United States $8.818B 23.42
Sonic Healthcare (SKHHY) Australia $8.465B 0.00
Charles River Laboratories (CRL) United States $7.445B 14.59
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.269B 25.15
BrightSpring Health Services (BTSG) United States $4.058B 37.23
Sotera Health (SHC) United States $3.225B 18.32
Surgery Partners (SGRY) United States $2.781B 36.17
Alignment Healthcare (ALHC) United States $2.722B 0.00
Concentras Parent (CON) United States $2.652B 15.33
Organon (OGN) United States $2.594B 2.76
GeneDx Holdings (WGS) United States $2.556B 98.45
PACS (PACS) United States $1.958B 0.00
Ardent Health (ARDT) United States $1.904B 8.12
Progyny (PGNY) United States $1.840B 40.49
Premier (PINC) United States $1.796B 13.63
GoodRx Holdings (GDRX) United States $1.761B 35.21
Teladoc Health (TDOC) United States $1.412B 0.00
Establishment Labs Holdings (ESTA) $1.181B 0.00
Pediatrix Medical (MD) United States $1.171B 8.91
CareDx (CDNA) United States $1.074B 16.77
Agilon Health (AGL) United States $0.956B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.806B 7.54
Nutex Health (NUTX) United States $0.658B 9.96
LifeMD (LFMD) United States $0.615B 0.00
Embecta (EMBC) United States $0.542B 3.65
InnovAge Holding (INNV) United States $0.532B 0.00
Enhabit (EHAB) United States $0.482B 39.62
Auna S.A (AUNA) Luxembourg $0.470B 10.58
SBC Medicals (SBC) United States $0.464B 0.00
Omada Health (OMDA) $0.460B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
Performant Healthcare (PHLT) United States $0.312B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.249B 0.00
Beauty Health (SKIN) United States $0.244B 0.00
So-Young (SY) China $0.209B 0.00
Oncology Institute (TOI) United States $0.200B 0.00
DocGo (DCGO) United States $0.172B 28.17
Pheton Holdings (PTHL) China $0.115B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.096B 0.00
KindlyMD (NAKA) United States $0.089B 0.00
Sera Prognostics (SERA) United States $0.075B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
ModivCare (MODV) United States $0.051B 0.00
Biodesix (BDSX) United States $0.041B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.033B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00